TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $1.01M invested in Theriva Biologics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.93K
2
+$4.03K

Top Sellers

1
-$14.4K
2
-$9.1K
3
-$7.46K
4
Bank of America
Bank of America
North Carolina
-$14
5
Morgan Stanley
Morgan Stanley
New York
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$525K
2
$190K
3
$116K
4
$48.7K
5
$39K
6
$28.5K
7
$26.6K
8
$13.6K
9
$12.6K
10
$5.93K
11
$382
12
$145
13
$109
14
$47
15
$14
16
$12
17
$6
18
–
19
–